PUBLIC CONTRACT · 2025

1358/2025 - Convite à apresentação de proposta por ajuste direto para aquisição de B466 - BOSENTANO [32 MG; COMP DISP], B925 - BEDAQUILINA [100 MG; CÁP/COMP], T1818 - TECLISTAMAB [90 MG/ML; 1,7 ML; SO

Contract value: €5,784.19
Signed on: 7 February 2025
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 11290657

PUBLISHED SUBJECT

WHO CONTRACTED

Parties involved

Contracting body: Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
Awardee: JANSSEN CILAG FARMACEUTICA, LDA.
Place of performance: Portugal, Porto, Porto
NUTS region: PT11A - Área Metropolitana do Porto

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: JANSSEN CILAG FARMACEUTICA, LDA. · Tax ID 500189412

HOW MUCH AND WHEN

Values and timeline

Contract price: €5,784.19
Procedure base price: €6,320,496.75
Total effective price: Not reported on Portal BASE
Publication date: 18 March 2025
Award date: 7 February 2025
Signing date: 7 February 2025
Performance period: 365 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea ii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: Not stated
Centralised procedure: Yes
Environmental criterion: No
Notice: Not stated
Procedure identifier: 7436675

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts